Christoph Broja
Direktor/Vorstandsmitglied bei Cardior Pharmaceuticals GmbH
Ursprung des Netzwerks ersten Grades von Christoph Broja
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
23
| Subsidiary | Investment Managers | 23 |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts.
5
| Private Company | Investment Managers | 5 |
Franz Haniel & Cie. GmbH
Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany.
4
| Subsidiary | Investment Managers | 4 |
EQT Life Sciences (Munich)
1
| Subsidiary | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christoph Broja
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Founder Private Equity Analyst Private Equity Investor Private Equity Investor Investment Committee Member Private Equity Investor Private Equity Investor Private Equity Investor Director of Finance/CFO Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor General Counsel Private Equity Analyst General Counsel | |
Vrije Universiteit Amsterdam | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
TAKKT AG | Wholesale Distributors | Chairman Director/Board Member Director/Board Member | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chairman Chief Executive Officer | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of Freiburg | College/University | Undergraduate Degree Doctorate Degree | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
SARTORIUS AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Alladapt Immunotherapeutics, Inc.
Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Wuppermann AG
Wuppermann AG SteelNon-Energy Minerals Wuppermann AG manufactures rolled steel sheets, tubes and other steel products. It produces products such as flat rolled steel, tubes, profiles, sheet metal parts, and integrated components made of steel, stainless steel and aluminum. The firm serves engineering, construction, furniture, medical equipment, food, and packaging industries. The company was founded by Theodor Wuppermann in 1872 and is headquartered in Leverkusen, Germany. | Steel | Chairman Director/Board Member | |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
McKinsey & Co., Inc. (Belgium)
McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BMEYE BV
BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | Investment Managers | Director/Board Member Chief Operating Officer | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ABLYNX | Biotechnology | Chairman Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
University of Leiden | College/University | Undergraduate Degree Doctorate Degree | |
LSP Services Deutschland GmbH | Investment Managers | President Private Equity Analyst | |
Health Economics Privak II NV
Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Neuravi Ltd.
Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
University of Twente | College/University | Corporate Officer/Principal Graduate Degree | |
ViCentra BV
ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
MERUS N.V. | Biotechnology | Chairman Director/Board Member | |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Corporate Officer/Principal | |
Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
Mint Solutions Holding BV
Mint Solutions Holding BV Electronic Equipment/InstrumentsElectronic Technology Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree |
Statistik
International
Niederlande | 17 |
Vereinigte Staaten | 10 |
Belgien | 9 |
Deutschland | 8 |
Vereinigtes Königreich | 5 |
Sektoral
Health Technology | 21 |
Consumer Services | 12 |
Finance | 8 |
Commercial Services | 6 |
Electronic Technology | 4 |
Operativ
Director/Board Member | 272 |
Corporate Officer/Principal | 53 |
Private Equity Investor | 50 |
Chairman | 49 |
Doctorate Degree | 25 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Stefan Mario Meister | 57 |
Martijn Kleijwegt | 33 |
Russell Greig | 31 |
René Kuijten | 30 |
Rudy Dekeyser | 29 |
Joachim Rothe | 22 |
John Paul de Koning | 21 |
Klaus Rüdiger Trützschler | 20 |
Sophie Kornowski-Bonnet | 16 |
Anne Portwich | 16 |
Ronald Cami | 15 |
Markus Hosang | 15 |
Vincent Brichard | 15 |
Bruno Luc Myriam Holthof | 14 |
David S. Moore | 13 |
- Börse
- Insiders
- Christoph Broja
- Unternehmensverbindungen